The pharmaceutical main had earlier introduced a closing dividend of Rs 8 per fairness share of face worth Re 1 every.
“We want to inform you that the Board of Administrators of the Firm, at their assembly held on Might 9, 2025, has inter alia transacted and authorised the next companies: Really useful a closing dividend of Rs. 8/- per fairness share of Rs. 1/- every for the monetary yr 2024-25,” the corporate mentioned in a earlier submitting to the inventory exchanges.
The report date for the dividend has been set as Wednesday, July 10, 2025. Which means that traders who need to obtain the dividend should buy the shares earlier than the ex-dividend date, which is at the moment.
Underneath commonplace settlement timelines adopted by Indian inventory exchanges, trades take two working days (T+1) to settle. Due to this fact, solely these shareholders whose names seem within the firm’s register of members as of the report date — July 10 — might be eligible to obtain the dividend.
To make sure that the shares are credited in time, traders should purchase Dr Reddy’s shares no later than July 9. Due to this fact, traders eyeing the dividend profit should guarantee to finish their buy of Dr Reddy’s shares earlier than the market closes at the moment.The shares of Dr. Reddy’s Laboratories closed 2% decrease at Rs 1,283.90 on the BSE on Tuesday.(Disclaimer: Suggestions, recommendations, views and opinions given by the specialists are their very own. These don’t characterize the views of The Financial Occasions)
